Human medicines European public assessment report (EPAR): Desloratadine Teva, desloratadine, Date of authorisation: 24/11/2011, Revision: 19, Status: Authorised
European Medicines Agency’s data protection notice for meeting registration forms via Microsoft Forms
European Medicines Agency’s data protection notice for conducting surveys via Microsoft Forms
European Medicines Agency’s data protection notice for conducting surveys via EUSurvey
European Medicines Agency’s data protection notice for meeting registration forms via EUSurvey
List of changes to combined Veterinary Dictionary for Drug Regulatory Activities (VeDDRA) list of clinical terms for reporting suspected adverse events in animal and humans to veterinary medicinal products for 2025
Vyvgart
Combined VeDDRA list of clinical terms for reporting suspected adverse events in animals and humans to veterinary medicinal products
Antimicrobial Sales and Use (ASU) Platform: Release notes
SPOR and XEVMPD status update webinar - Q3 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 8 July 2026, 10:00 (CEST) to 8 July 2026, 12:30 (CEST)